InsidersTradesSigma
Track the 君实生物 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 君实生物 has recorded 2 reports. Market capitalisation: €36.8bn. The latest transaction was reported on 31 March 2026 (Purchase). Among the most active insiders: 熊俊. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
君实生物是一家专注于医疗保健和制药领域的公司，致力于创新疗法的研发。该公司在XSHG市场上市。